Litcius/Paper detail

CPI-0610, a Bromodomain and Extraterminal Domain Protein (BET) Inhibitor, As Monotherapy in Advanced Myelofibrosis Patients Refractory/Intolerant to JAK Inhibitor: Update from Phase 2 MANIFEST Study

Moshe Talpaz

202062nd ASH Annual Meeting and Exposition14 citations

Topics & Concepts

BromodomainRefractory (planetary science)MyelofibrosisMedicineBET inhibitorInternal medicineBiologyBiochemistryAcetylationGeneAstrobiologyBone marrowMultiple Myeloma Research and TreatmentsMyeloproliferative Neoplasms: Diagnosis and TreatmentProtein Degradation and Inhibitors
CPI-0610, a Bromodomain and Extraterminal Domain Protein (BET) Inhibitor, As Monotherapy in Advanced Myelofibrosis Patients Refractory/Intolerant to JAK Inhibitor: Update from Phase 2 MANIFEST Study | Litcius